Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development

Author： Stanwood G.D.   Levitt P.  

Publisher： Elsevier

ISSN： 1471-4892

Source： Current Opinion in Pharmacology, Vol.4, Iss.1, 2004-02, pp. : 65-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

In Silico Prediction of Brain Exposure: Drug Free Fraction, Unbound Brain to Plasma Concentration Ratio and Equilibrium Half-Life

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-04 ,pp. : 813-820

Bentham Science Publishers

Access to resources Recommend Favorite

Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry

By Zhang M.-Y.   Kerns E.   McConnell O.   Sonnenberg-Reines J.   Zaleska M.M.   Steven Jacobsen J.   Butera J.   Kreft A.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 34, Iss. 2, 2004-02 ,pp. : 359-368

Elsevier

Access to resources Recommend Favorite

Functional genomics in neuropsychiatric disorders and in neuropharmacology

By Castrén Eero   Kontkanen Outi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 363-374

Informa Healthcare

Access to resources Recommend Favorite

Concentration and Persistence of Tin in Rat Brain and Blood Following Dibutyltin Exposure During Development

By Moser V. C.   McGee J. K.   Ehman K. D.  

Journal of Toxicology and Environmental Health, Vol. 72, Iss. 1, 2009-01 ,pp. : 47-52

Taylor & Francis Ltd

Access to resources Recommend Favorite

Modelling during drug development

By Balant L.P.   Gex-Fabry M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 13-26

Elsevier

Access to resources Recommend Favorite